<unk>  (trade names include Amerge) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. It is a selective 5-HT1 receptor subtype agonist. It was patented in 1987 and approved for medical use in 1997.
Naratriptan
Sumatriptan
Eletriptan
Frovatriptan
Rizatriptan
Almotriptan
Triptan
Zolmitriptan